EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy
Kerstin Kapp, Barbara Volz, Michael A. Curran, Detlef Oswald, Burghardt Wittig, Manuel Schmidt
Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 5; DOI: 10.1186/s40425-018-0470-3